Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Available for licensing from NIH: T-cell epitopes from NY-ESO-1 cancer antigen

Feb. 20, 2001

Cyclacel to evaluate lead CDK2 inhibitor in phase I

Feb. 19, 2001

AEterna enters two commercialization alliances for Neovastat in Europe

Feb. 19, 2001

EntreMed expands phase II 2ME2 program to include prostate cancer

Feb. 19, 2001

GenVec begins phase I clinical trial with TNFerade

Feb. 16, 2001

Merck's new oligopeptide-cytotoxic agent conjugates useful for Rx of cancer, BPH

Feb. 16, 2001

Maxim receives SBIR grants for evaluation of anticancer agents

Feb. 16, 2001

SuperGen obtains certain rights to VTA technology

Feb. 16, 2001

Onconase receives orphan medicinal product designation in Europe

Feb. 15, 2001

Antitumor agents derived from UCF-116 result from Kyowa Hakko-Lilly collaboration

Feb. 15, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.